Sebastien Milesi1, Badreddine Boussadia1, Clement Plaud1, Matthias Catteau1, Marie-Claude Rousset1, Frederic De Bock1, Marie Schaeffer2, Mireille Lerner-Natoli1, Valerie Rigau3, Nicola Marchi4. 1. Laboratory of Cerebrovascular Mechanisms of Brain Disorders, Department of Neuroscience, Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, 2, France. 2. Laboratory of Networks and Rhythms in Endocrine Glands, Department of Physiology, Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, 2, France. 3. Pathology Department, University Hospital Gui de Chauliac, Montpellier, France. 4. Laboratory of Cerebrovascular Mechanisms of Brain Disorders, Department of Neuroscience, Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, 2, France. Electronic address: nicola.marchi@igf.cnrs.fr.
Abstract
PURPOSE: The role of cerebrovascular dysfunction in seizure disorders is recognized. Blood-brain barrier (BBB) damage in epilepsy has been linked to endothelial and glial pathophysiological changes. Little is known about the involvement of pericytes, a cell type that contributes to BBB function. METHODS: NG2DsRed mice were used to visualize cerebrovascular pericytes. The pattern of vascular and parenchymal distributions of platelet-derived growth factor receptor beta (PDGFRβ) cells was evaluated by immunohistochemistry. Status epilepticus was induced in NG2DsRed or C57BL/6J mice by intraperitoneal kainic acid (KA). Animals were perfused intracardially using FITC-Dextran or FITC-Albumin to visualize the cerebrovasculature. Colocalization was performed between NG2DsRed, PDGFRβ and microglia IBA-1. Confocal 3D vessel reconstruction was used to visualize changes in cell morphology and position. PDGFRβ expression was also evaluated in vitro using organotypic hippocampal cultures (OHC) treated with kainic acid to induce seizure-like activity. Co-localization of PDGFRβ with the vascular marker RECA-1 and NG2 was performed. Finally, we assessed the expression of PDGFRβ in brain specimens obtained from a cohort of patients affected by drug resistant epilepsy compared to available autoptic brain. RESULTS: In vivo, severe status epilepticus (SE) altered NG2DsRed vascular coverage. We found dishomogenous NG2DsRed perivascular ramifications after SE and compared to control. Concomitantly, PDGFRβ(+) cells re-distributed towards the cerebrovasculature after severe SE. Cerebrovascular NG2DsRed partially colocalized with PDGFRβ(+) while parenchymal PDGFRβ(+) cells did not colocalize with IBA-1(+) microglia. Using in vitro OHC we found decreased NG2 vascular staining and increased PDGFRβ(+) ramifications associated with RECA-1(+) microvessels after seizure-like activity. Cellular PDGFRβ and NG2(+) colocalization was observed in the parenchyma. Finally, analysis of human TLE brains revealed perivascular and parenchymal PDGFRβ(+) cell distributions resembling the murine in vivo and in vitro results. PDGFRβ(+) cells at the cerebrovasculature were more frequent in TLE brain tissues as compared to the autoptic control. CONCLUSIONS: The rearrangement of PDGFRβ(+) and vascular NG2DsRed cells after SE suggests a possible involvement of pericytes in the cerebrovascular modifications observed in epilepsy. The functional role of vascular-parenchymal PDGFRβ(+) cell redistribution and the relevance of a pericyte response to SE remain to be fully elucidated.
PURPOSE: The role of cerebrovascular dysfunction in seizure disorders is recognized. Blood-brain barrier (BBB) damage in epilepsy has been linked to endothelial and glial pathophysiological changes. Little is known about the involvement of pericytes, a cell type that contributes to BBB function. METHODS: NG2DsRed mice were used to visualize cerebrovascular pericytes. The pattern of vascular and parenchymal distributions of platelet-derived growth factor receptor beta (PDGFRβ) cells was evaluated by immunohistochemistry. Status epilepticus was induced in NG2DsRed or C57BL/6J mice by intraperitoneal kainic acid (KA). Animals were perfused intracardially using FITC-Dextran or FITC-Albumin to visualize the cerebrovasculature. Colocalization was performed between NG2DsRed, PDGFRβ and microglia IBA-1. Confocal 3D vessel reconstruction was used to visualize changes in cell morphology and position. PDGFRβ expression was also evaluated in vitro using organotypic hippocampal cultures (OHC) treated with kainic acid to induce seizure-like activity. Co-localization of PDGFRβ with the vascular marker RECA-1 and NG2 was performed. Finally, we assessed the expression of PDGFRβ in brain specimens obtained from a cohort of patients affected by drug resistant epilepsy compared to available autoptic brain. RESULTS: In vivo, severe status epilepticus (SE) altered NG2DsRed vascular coverage. We found dishomogenous NG2DsRed perivascular ramifications after SE and compared to control. Concomitantly, PDGFRβ(+) cells re-distributed towards the cerebrovasculature after severe SE. Cerebrovascular NG2DsRed partially colocalized with PDGFRβ(+) while parenchymal PDGFRβ(+) cells did not colocalize with IBA-1(+) microglia. Using in vitro OHC we found decreased NG2 vascular staining and increased PDGFRβ(+) ramifications associated with RECA-1(+) microvessels after seizure-like activity. Cellular PDGFRβ and NG2(+) colocalization was observed in the parenchyma. Finally, analysis of humanTLE brains revealed perivascular and parenchymal PDGFRβ(+) cell distributions resembling the murine in vivo and in vitro results. PDGFRβ(+) cells at the cerebrovasculature were more frequent in TLE brain tissues as compared to the autoptic control. CONCLUSIONS: The rearrangement of PDGFRβ(+) and vascular NG2DsRed cells after SE suggests a possible involvement of pericytes in the cerebrovascular modifications observed in epilepsy. The functional role of vascular-parenchymal PDGFRβ(+) cell redistribution and the relevance of a pericyte response to SE remain to be fully elucidated.
Authors: Vishnu Chintalgattu; Di Ai; Robert R Langley; Jianhu Zhang; James A Bankson; Tiffany L Shih; Anilkumar K Reddy; Kevin R Coombes; Iyad N Daher; Shibani Pati; Shalin S Patel; Jennifer S Pocius; George E Taffet; L Maximillian Buja; Mark L Entman; Aarif Y Khakoo Journal: J Clin Invest Date: 2010-01-11 Impact factor: 14.808
Authors: Ethan A Winkler; Jesse D Sengillo; Robert D Bell; Joseph Wang; Berislav V Zlokovic Journal: J Cereb Blood Flow Metab Date: 2012-08-01 Impact factor: 6.200
Authors: Gabryella S P Santos; Luiz A V Magno; Marco A Romano-Silva; Akiva Mintz; Alexander Birbrair Journal: Neurosci Bull Date: 2018-10-26 Impact factor: 5.203
Authors: Adriana Fernanda K Vizuete; Matheus Mittmann Hennemann; Carlos Alberto Gonçalves; Diogo Losch de Oliveira Journal: Neurochem Res Date: 2017-04-25 Impact factor: 3.996